Regulatory class, clinical buyer, and candidate access shape every medical device search.
The talent market hasn't kept pace with industry growth.Biotech, diagnostics, and life science tools have expanded significantly over the past decade — the specialized talent pool has grown more slowly. Multiple companies are competing for the same short list of candidates.
Tenures have shortened along the way: three years at one company is becoming the norm, which means more candidates are technically "available" but the strongest performers are harder to catch at the right moment. Compensation has shifted faster than most hiring managers realize, and companies relying on outdated comp data lose candidates to better-informed competitors before getting to a serious conversation.
Specialist-led searches fill faster and produce better fits. Generalists know the roles but not the people, not the compensation, and not the timing.Technical and commercial recruiting are different disciplines.Treating them as interchangeable is the most common reason life science searches stall.
Technical candidates — scientists, regulatory leaders, engineers — evaluate opportunities based on the science, the pipeline, and the technical leadership. Compensation matters, but it's rarely the deciding factor.
Commercial candidates weigh territory, quota structure, product competitiveness, and growth trajectory. The screening questions, the pitch, and the close all look different.Most generalist recruiters default to the commercial playbook for both — and lose their strongest technical candidates in the first call.
A recruiter who can't speak credibly about the science can't recruit scientists.Company stage matters as much as functional fit.A technically perfect candidate at the wrong stage is still a wrong hire — and in life sciences, where time-to-productivity is long, those mismatches show up on the P&L.
Early-stage companies need builders comfortable with ambiguity; pedigree matters less than adaptability.
Mid-stage companies need people who can bridge startup energy and operational structure — the trickiest stage transition and where pedigree-focused recruiters most often miss.
Large pharma and established diagnostics need candidates who can navigate matrix organizations, longer decision cycles, and global stakeholders.A strong life science search starts with understanding the company's stage and culture, not just the role. The candidates who look right on paper often aren't — and the candidates who don't look obvious are often the ones who actually work out.
